Inhibrx Q3 Loss Widens to $2.46 a Share; INBX Fell 5% Before the Report
Inhibrx's third-quarter loss grew to $2.46 per share as interest costs rose on a larger loan. The stock had already closed down 5.07% on Friday before the 4:02 p.m. ET release.
Inhibrx's third-quarter loss grew to $2.46 per share as interest costs rose on a larger loan. The stock had already closed down 5.07% on Friday before the 4:02 p.m. ET release.
Suncrete's third-quarter revenue rose to $141.0 million and net income edged above zero, while 2026 guidance still implies a loss. The stock jumped after hours on Thursday, before the report, and the regular session had not yet opened.
Tetra Tech's adjusted EPS edged past estimates and its fiscal 2027 guidance straddled analyst forecasts. Shares gapped up 10% on Nov. 12, then sold off to close 4.84% above the Nov. 11 close.
Enovix gapped down 10.28% at the open on Nov. 12 after results, then fell further to close 28.66% below its Nov. 11 close. The session shows how an earnings gap can extend instead of fill.
Digi reported 25% revenue growth for its fiscal fourth quarter on Nov. 11, yet shares closed Nov. 12 down 12.72% after opening 20.71% lower. Guidance sat at or above analyst estimates, so the cause of the selloff is unclear.